By inhibiting TGFβ in combination with PD-1/PD-L1 blockade, CD8+ T cells also display enhanced capacity to infiltrate the tumor periphery and core, promoting T cell inflammation, and resolving T cell exclusion (113, 117). The gene discussed is CD274; the disease is neoplasm.